We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04700072
Brief Title: Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)

First Submitted : January 5, 2021
First Submitted that Met QC Criteria : January 5, 2021
First Posted : January 7, 2021

Last Update Submitted that Met QC Criteria : January 25, 2023
Last Update Posted : January 26, 2023